Therapeutic Goods (Permissible Indications) Determination (No. 1) 2021

This Determination sets out the list of permitted therapeutic claims (indications) which may be made in relation to medicines that are listed on the Australian Register of Therapeutic Goods (ARTG) under sections 26A, or 26AE, of the Therapeutic Goods Act 1989 (these are listed, and listed assessed medicines).

Official version of legislation
The Federal Register of Legislation is the authorised Australian Government website for Commonwealth legislation. It contains the full text and details of the life cycle of individual laws.

Read the legislation

Guidance referring to this legislation

Understanding the application requirements for an assessed listed medicine

21 November 2024

Guidance

Guidance on the regulatory requirements for assessed listed medicines.
Using the Permissible Ingredients Determination for listed and assessed listed medicines

1 December 2020

Guidance

Guidance on how to access and use the Permissible Ingredients Determination for the purposes of submitting applications for substances in listed and assessed listed medicines.

Topics

Sub menu

Therapeutic Goods (Permissible Indications) Determination (No. 1) 2021

Official version of legislation

Guidance referring to this legislation

Understanding the application requirements for an assessed listed medicine

Using the Permissible Ingredients Determination for listed and assessed listed medicines

Help us improve the Therapeutic Goods Administration site